Literature DB >> 9934892

Distribution of normal saline and 5% albumin infusions in septic patients.

D Ernest1, A S Belzberg, P M Dodek.   

Abstract

OBJECTIVE: To determine the relative distribution of fluid within the extracellular fluid volume (ECFV) after infusing either normal saline or 5% albumin in septic, critically ill patients.
DESIGN: Prospective, randomized, unblinded, interventional study.
SETTING: Intensive care unit in a 450-bed, tertiary care, teaching hospital. PATIENTS: Septic, critically ill patients (n = 18).
INTERVENTIONS: Infusion of either normal saline or 5% albumin to a hemodynamic end point determined by the patient's clinician.
MEASUREMENTS AND MAIN RESULTS: Plasma volume (PV), ECFV, cardiac index, and arterial oxygen content were measured immediately before (baseline) and after each fluid infusion. PV and ECFV were measured by dilution of 131I-albumin and 35S sodium sulfate, respectively. Interstitial fluid volume (ISFV) was calculated as ECFV - PV. Baseline values for PV, ISFV, ECFV, and oxygen delivery index did not differ between treatment groups. Infusion of normal saline increased the ECFV by approximately the volume infused, and the expansion of the PV to ISFV was in a ratio of 1:3. Infusion of 5% albumin increased the ECFV by double the volume infused, with both the PV and ISFV expanding by approximately equal amounts. Oxygen delivery index did not increase after either infusion due to the effect of hemodilution.
CONCLUSION: Expansion of the ECFV in excess of the volume of 5% albumin infused suggests that fluid may move from the intracellular fluid volume to the ECFV in septic patients who receive this fluid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934892     DOI: 10.1097/00003246-199901000-00025

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  27 in total

Review 1.  Human albumin solution for resuscitation and volume expansion in critically ill patients.

Authors:  Ian Roberts; Karen Blackhall; Phil Alderson; Frances Bunn; Gillian Schierhout
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Fluid resuscitation in neonatal and pediatric hypovolemic shock: a Dutch Pediatric Society evidence-based clinical practice guideline.

Authors:  Nicole Boluyt; Casper W Bollen; Albert P Bos; Joke H Kok; Martin Offringa
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

3.  Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.

Authors:  William R Hand; Joseph R Whiteley; Tom I Epperson; Lauren Tam; Heather Crego; Bethany Wolf; Kenneth D Chavin; David J Taber
Journal:  Anesth Analg       Date:  2015-03       Impact factor: 5.108

4.  Beyond the fluid bolus.

Authors:  Peter Bentzer; Anja Lindén-Søndersø
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 5.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

6.  Should colloid boluses be prioritized over crystalloid boluses for the management of dengue shock syndrome in the presence of ascites and pleural effusions?

Authors:  Ranjan Premaratna; Erandi Liyanaarachchi; Mindu Weerasinghe; H Janaka de Silva
Journal:  BMC Infect Dis       Date:  2011-02-28       Impact factor: 3.090

7.  Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia.

Authors:  Ronald J Trof; Sharwan P Sukul; Jos W R Twisk; Armand R J Girbes; A B Johan Groeneveld
Journal:  Intensive Care Med       Date:  2010-02-18       Impact factor: 17.440

Review 8.  CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients.

Authors:  Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

9.  Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial.

Authors:  Thiemo F Veneman; Jeroen Oude Nijhuis; Arend J J Woittiez
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

10.  Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation.

Authors:  Lukas Bruegger; Peter Studer; Stefan W Schmid; Gunther Pestel; Juerg Reichen; Christian Seiler; Daniel Candinas; Daniel Inderbitzin
Journal:  J Gastrointest Surg       Date:  2007-10-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.